Attributes | Values |
---|
rdf:type
| |
Description
| - To evaluate the effect of a combination of intraluminal brachytherapy and metallic stent implantation in the treatment of patients with nonresectable biliary tumors. Methodology: Thirty-two patients aged 41-80 years with nonresectable biliary malignancies - Klatskin's tumor (n = 17), gallbladder carcinoma (n = 11) and carcinoma of papilla Vateri (n = 4) - were treated with a combination of intraluminal brachytherapy (source Ir192, high-dose radiation regimen, total dose 30Gy) and metallic stent implantation. Intraluminal brachytherapy and stent insertion (metallic, spiral-Z stent) were performed percutaneously in all patients. Results: The mean survival in patients with Klatskin's tumor was 457 days (range: 64-1186; median: 358 days), in patients with gallbladder carcioma 237 days (range: 92-609; median: 210 days) and in patients with carcinoma of papilla Vateri 850 days (range: 48-1518; median: 1277 days). The rate of 2-year survival in these groups was 27, 0 and 50%, respectively. The surv
- To evaluate the effect of a combination of intraluminal brachytherapy and metallic stent implantation in the treatment of patients with nonresectable biliary tumors. Methodology: Thirty-two patients aged 41-80 years with nonresectable biliary malignancies - Klatskin's tumor (n = 17), gallbladder carcinoma (n = 11) and carcinoma of papilla Vateri (n = 4) - were treated with a combination of intraluminal brachytherapy (source Ir192, high-dose radiation regimen, total dose 30Gy) and metallic stent implantation. Intraluminal brachytherapy and stent insertion (metallic, spiral-Z stent) were performed percutaneously in all patients. Results: The mean survival in patients with Klatskin's tumor was 457 days (range: 64-1186; median: 358 days), in patients with gallbladder carcioma 237 days (range: 92-609; median: 210 days) and in patients with carcinoma of papilla Vateri 850 days (range: 48-1518; median: 1277 days). The rate of 2-year survival in these groups was 27, 0 and 50%, respectively. The surv (en)
|
Title
| - Intraluminal brachytherapy and selfexpandable stents in nonresectable biliary malignancies - The question of long-term palliation
- Intraluminal brachytherapy and selfexpandable stents in nonresectable biliary malignancies - The question of long-term palliation (en)
|
skos:prefLabel
| - Intraluminal brachytherapy and selfexpandable stents in nonresectable biliary malignancies - The question of long-term palliation
- Intraluminal brachytherapy and selfexpandable stents in nonresectable biliary malignancies - The question of long-term palliation (en)
|
skos:notation
| - RIV/00216208:11120/01:00003684!RIV12-MSM-11120___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00216208:11120/01:00003684
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - biliary tumor; percutaneous biliary drainage; metallic stent; intraluminal brachytherapy (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - DE - Spolková republika Německo
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Kubecová, Martina
- Brůha, Radan
- Chodounský, Zdeněk
|
http://linked.open...ain/vavai/riv/wos
| |
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |